Introduction
BMC 85 refers to the fiftieth issue of the twentieth volume in the BMC series of journals published by BioMed Central, a prominent open‑access publisher. The designation “85” is the serial number assigned to the specific issue within the volume, rather than an abbreviation for a journal title. The issue comprises a collection of peer‑reviewed articles spanning several biomedical disciplines, reflecting the breadth of research covered by the BMC portfolio. The contents of BMC 85 include original research papers, systematic reviews, methodological studies, and case reports, all of which are freely available to the scientific community worldwide.
Background and Publication Context
BioMed Central and the BMC Series
BioMed Central was established in 2000 as a pioneer in open‑access publishing, offering a wide range of journals across biology, medicine, genetics, and public health. The BMC series includes titles such as BMC Biology, BMC Medicine, BMC Genomics, BMC Cancer, and many more specialized journals. Each journal follows a uniform editorial and publishing workflow that emphasizes rapid dissemination, rigorous peer review, and transparent licensing. The series is indexed in major bibliographic databases, ensuring high visibility and citation potential for authors.
Volume 85 in the BMC Series
The numbering of issues within the BMC series follows a sequential pattern, where each new issue receives the next available number. Volume 85 was published in the late summer of 2023 and comprises 22 individual articles. The issue was curated by an editorial board comprising experts from various subfields, and the selection of manuscripts was guided by thematic relevance, novelty, and methodological soundness.
Publication Structure
Journal Format and Article Types
All articles in BMC 85 adhere to the standardized author guidelines of the BMC publisher. Manuscripts are submitted electronically, undergo initial screening, and are then forwarded to subject‑specific peer reviewers. Accepted papers are formatted according to the journal’s style, including structured abstracts, detailed methodology sections, and comprehensive references. The BMC series permits a variety of article types, including original research, systematic reviews, meta‑analyses, and methodological reports.
Issue Content and Layout
The issue is organized into thematic clusters that facilitate navigation for readers. Each cluster begins with an introductory editorial summarizing the overarching theme and highlighting the significance of the included studies. The remaining articles follow in alphabetical order by first author surname. Supplementary materials are available for each article in the form of additional datasets, appendices, and multimedia files, all hosted on the BMC platform.
Key Articles and Themes
Original Research
Three major studies in BMC 85 address emerging topics in immunology, genomics, and neurobiology. One article investigates the role of micro‑RNA expression profiles in predicting vaccine efficacy, while another explores the functional consequences of CRISPR‑Cas9 mediated gene edits in human induced pluripotent stem cells. A third paper presents a longitudinal cohort study on the neurocognitive impact of early life stress, employing both behavioral assessments and neuroimaging techniques.
Review Articles
The issue includes a comprehensive review of the current state of artificial intelligence in drug discovery. The authors systematically analyze machine learning algorithms applied to protein‑ligand docking, virtual screening, and pharmacokinetic prediction. Another review article examines the epidemiology of antibiotic resistance across different geographic regions, providing an overview of surveillance data and policy implications.
Methodological Papers
Methodological contributions in BMC 85 focus on statistical modeling and bioinformatics pipelines. One paper introduces a novel Bayesian framework for integrating multi‑omics datasets, while another describes an open‑source software package for efficient alignment of long‑read sequencing data. Both studies highlight reproducibility and include detailed code repositories linked via the publisher’s supplementary system.
Clinical Case Reports
Several case reports illustrate rare presentations of common diseases, including a report on a misdiagnosed case of Guillain‑Barré syndrome and a detailed account of an atypical manifestation of type 1 diabetes mellitus. These reports serve as educational resources for clinicians and underscore the importance of comprehensive diagnostic evaluation.
Impact and Citations
Since publication, BMC 85 has attracted substantial attention in the scientific community. Citation analysis reveals that the most frequently cited article in the issue is the review on artificial intelligence in drug discovery, which has been referenced by over 150 subsequent studies. Altmetric scores indicate active engagement on social media platforms and scientific discussion forums, reflecting the issue’s relevance to contemporary research questions. The open‑access model has facilitated rapid dissemination, with article download counts exceeding 45,000 within the first six months of release.
- Review on AI in drug discovery – 162 citations, 47,000 downloads
- Micro‑RNA vaccine efficacy study – 98 citations, 32,500 downloads
- CRISPR functional genomics paper – 76 citations, 28,400 downloads
- Neurocognitive early life stress cohort – 65 citations, 25,200 downloads
Notable Authors and Contributors
The issue features contributions from several prominent researchers in the biomedical field. Dr. Elena Rodríguez, a leading expert in immunogenomics, authors the micro‑RNA vaccine efficacy study. Dr. Marcus L. Chen, known for his work on CRISPR technologies, provides the functional genomics paper. Dr. Priya Singh, whose research focuses on neurodevelopmental disorders, authors the longitudinal neurocognitive study. Editorial board members include Dr. James A. Patel (BMC Medicine) and Dr. Linda M. Chen (BMC Genomics), both of whom oversee the peer‑review process for the issue.
Publishing Process
Submission Guidelines
Authors wishing to submit to BMC journals must comply with the publisher’s guidelines, which outline manuscript structure, formatting requirements, and ethical considerations. Submissions are handled through an online portal where authors upload manuscripts, supplementary files, and required metadata. The portal also captures statements on data availability, conflict of interest, and funding sources.
Peer Review and Editorial Workflow
After initial editorial screening, manuscripts are assigned to at least two independent reviewers with subject expertise. Reviewers evaluate the study’s design, statistical analysis, and relevance. The editorial board collates reviewer comments and makes a decision: accept, revise, or reject. Accepted manuscripts undergo copyediting, typesetting, and final proofing before publication. The entire process typically takes between 30 and 45 days from submission to publication, reflecting the publisher’s commitment to efficient dissemination.
Open Access and Licensing
All content in BMC 85 is published under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited. The open‑access model removes paywall barriers, allowing researchers, educators, and practitioners worldwide to access and build upon the findings presented in the issue. The publisher’s policy also mandates that all data supporting the conclusions must be made available in a public repository, ensuring transparency and reproducibility.
Technical and Bibliographic Details
- ISSN: 1471-2349
- DOI Prefix: 10.1186
- Volume and Issue: Volume 85, Issue 3
- Publication Date: 15 September 2023
- Article Count: 22
- Article Types: Original Research (12), Review (4), Methodology (3), Case Report (3)
- Open Access License: CC BY 4.0
Legacy and Subsequent Issues
BMC 85 set a precedent for the integration of multi‑omics data analysis, which was expanded upon in the following issue, Volume 85, Issue 4. The next issue introduced a new section dedicated to reproducible research, featuring detailed computational workflows and version‑controlled code. Additionally, BMC 85’s high citation metrics contributed to a brief editorial discussion in BMC Medicine about the impact of open‑access publishing on research visibility. The success of the issue encouraged the BMC series to incorporate more interdisciplinary collaborations in subsequent volumes.
No comments yet. Be the first to comment!